BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 2752594)

  • 1. Anti-gliadin antibody specificity for gluten-derived peptides toxic to coeliac patients.
    Devery JM; La Brooy JT; Krillis S; Davidson G; Skerritt JH
    Clin Exp Immunol; 1989 Jun; 76(3):384-90. PubMed ID: 2752594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation of serum and intestinal gluten antibody specificities in coeliac disease.
    Skerritt JH; Johnson RB; Hetzel PA; La Brooy JT; Shearman DJ; Davidson GP
    Clin Exp Immunol; 1987 Apr; 68(1):189-99. PubMed ID: 3652513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit.
    Kaukinen K; Collin P; Laurila K; Kaartinen T; Partanen J; Mäki M
    Scand J Gastroenterol; 2007 Dec; 42(12):1428-33. PubMed ID: 17852878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the antigliadin antibody titer in adult celiac disease].
    Ferfoglia G; Fusco P; Sategna-Guidetti C
    Recenti Prog Med; 1989 May; 80(5):245-8. PubMed ID: 2762662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wheat gliadin fractions and other cereal antigens reactive with antibodies in the sera of coeliac patients.
    Kieffer M; Frazier PJ; Daniels NW; Coombs RR
    Clin Exp Immunol; 1982 Dec; 50(3):651-60. PubMed ID: 7166001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No induction of anti-avenin IgA by oats in adult, diet-treated coeliac disease.
    Guttormsen V; Løvik A; Bye A; Bratlie J; Mørkrid L; Lundin KE
    Scand J Gastroenterol; 2008; 43(2):161-5. PubMed ID: 18224563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IgG subclass antibodies to gliadin and other dietary antigens in children with coeliac disease.
    Husby S; Foged N; Oxelius VA; Svehag SE
    Clin Exp Immunol; 1986 Jun; 64(3):526-35. PubMed ID: 3791689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How sensitive and specific is the determination of gliadin antibodies in the serum of patients with severe damage of small intestine mucosa?].
    Hebel E; Piske-Keyser K; Otten A; Wolf H
    Monatsschr Kinderheilkd; 1988 Aug; 136(8):459-61. PubMed ID: 3221894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum antibodies to gliadin and other cereal proteins in patients with coeliac disease and dermatitis herpetiformis.
    Kieffer M
    Dan Med Bull; 1985 Oct; 32(5):251-62. PubMed ID: 4053695
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent aspects of antibody determination for the diagnosis of coeliac disease].
    Mothes T; Uhlig HH; Richter T
    Dtsch Med Wochenschr; 2009 Jul; 134(30):1525-8. PubMed ID: 19603369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA anti-gliadin antibodies in coeliac disease.
    Unsworth DJ; Kieffer M; Holborow EJ; Coombs RR; Walker-Smith JA
    Clin Exp Immunol; 1981 Nov; 46(2):286-93. PubMed ID: 7039883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion of gliadin antibody by coeliac jejunal mucosal biopsies cultured in vitro.
    Ciclitira PJ; Ellis HJ; Wood GM; Howdle PD; Losowsky MS
    Clin Exp Immunol; 1986 Apr; 64(1):119-24. PubMed ID: 3731523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.
    Korponay-Szabó IR; Vecsei Z; Király R; Dahlbom I; Chirdo F; Nemes E; Fésüs L; Mäki M
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative approach to low-level gluten determination in foods using a novel sandwich enzyme-linked immunosorbent assay protocol.
    Valdés I; García E; Llorente M; Méndez E
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):465-74. PubMed ID: 12702901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to gliadin as a screening test for coeliac disease. A prospective study.
    Signer E; Bürgin-Wolff A; Berger R; Birbaumer A; Just M
    Helv Paediatr Acta; 1979 Feb; 34(1):41-52. PubMed ID: 372144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The production and characterisation of monoclonal antibodies to wheat gliadin peptides.
    Ellis HJ; Freedman AR; Ciclitira PJ
    J Immunol Methods; 1989 Jun; 120(1):17-22. PubMed ID: 2659671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of extended amino acid motifs for focussing on toxic peptides in coeliac disease.
    McLachlan A; Cullis PG; Cornell HJ
    J Biochem Mol Biol Biophys; 2002 Oct; 6(5):319-24. PubMed ID: 12385967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease.
    Tye-Din JA; Stewart JA; Dromey JA; Beissbarth T; van Heel DA; Tatham A; Henderson K; Mannering SI; Gianfrani C; Jewell DP; Hill AV; McCluskey J; Rossjohn J; Anderson RP
    Sci Transl Med; 2010 Jul; 2(41):41ra51. PubMed ID: 20650871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease.
    Hischenhuber C; Crevel R; Jarry B; Mäki M; Moneret-Vautrin DA; Romano A; Troncone R; Ward R
    Aliment Pharmacol Ther; 2006 Mar; 23(5):559-75. PubMed ID: 16480395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunofluorescent antibodies against gliadin: a screening test for coeliac disease.
    Bürgin-Wolff A; Hernandez R; Just M; Signer E
    Helv Paediatr Acta; 1976 Dec; 31(4-5):375-80. PubMed ID: 797680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.